| scholarly article | Q13442814 |
| P50 | author | Fredrik Granath | Q102407384 |
| Lena Björnådal | Q125311243 | ||
| Lars Klareskog | Q5912759 | ||
| P2093 | author name string | Anders Ekbom | |
| Li Yin | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| systemic lupus erythematosus | Q1485 | ||
| lupus erythematosus | Q188297 | ||
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 713-719 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95 | |
| P478 | volume | 31 |
| Q26785666 | "How many times must a man look up before he can really see the sky?" Rheumatic cardiovascular disease in the era of multimodality imaging |
| Q61454285 | "Save the Last Dance" for Cardiovascular Magnetic Resonance |
| Q35194978 | 17β-Estradiol protects against the progression of hypertension during adulthood in a mouse model of systemic lupus erythematosus |
| Q46080033 | 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study |
| Q36784328 | Association between depression and vascular disease in systemic lupus erythematosus |
| Q38026784 | B-cell depletion in the treatment of lupus nephritis |
| Q84583299 | Biological therapy for lupus nephritis-tribulations and trials |
| Q88405053 | Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015 |
| Q87997758 | Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives |
| Q39283998 | Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q90415557 | Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management |
| Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
| Q37294919 | Cystamine attenuates lupus-associated apoptosis of ventricular tissue by suppressing both intrinsic and extrinsic pathways |
| Q37521891 | ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis |
| Q45102525 | Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q35162962 | Estrogen in cardiovascular disease during systemic lupus erythematosus |
| Q37930979 | Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians |
| Q35382247 | Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literature |
| Q33758208 | Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort |
| Q92375497 | Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity |
| Q81536457 | Genetic contribution to carotid vascular disease in patients with systemic lupus erythematosus |
| Q64105008 | Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study |
| Q91887909 | High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus |
| Q35450156 | Imaging assessment of cardiovascular disease in systemic lupus erythematosus |
| Q34356411 | Impact of early life ovariectomy on blood pressure and body composition in a female mouse model of systemic lupus erythematosus |
| Q35145138 | Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study. |
| Q81698497 | Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus |
| Q79882247 | Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis |
| Q92550885 | L-sepiapterin restores SLE serum-induced markers of endothelial function in endothelial cells |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q37684625 | Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort |
| Q38777770 | Mortality in Systemic Lupus Erythematosus: an Updated Review. |
| Q33389669 | Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus |
| Q55185377 | Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. |
| Q39440991 | New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus. |
| Q52668758 | Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. |
| Q30409882 | Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus |
| Q36359128 | Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study |
| Q89448070 | Pediatric-onset systemic lupus erythematosus with coronary artery dilation: A case report |
| Q33387473 | Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study |
| Q37406201 | Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort |
| Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
| Q33766242 | Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study |
| Q55215256 | Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis. |
| Q37436729 | S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. |
| Q90285248 | SLE mortality remains disproportionately high, despite improvements over the last decade |
| Q47549484 | Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus. |
| Q84256255 | Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus |
| Q80194464 | Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center |
| Q34017775 | Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study |
| Q35620319 | The Root Extract of Gentiana macrophylla Pall. Alleviates Cardiac Apoptosis in Lupus Prone Mice |
| Q28069667 | The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease |
| Q45092952 | The early cardiovascular changes in pediatric patients with systemic lupus erythematosus |
| Q57061710 | The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography |
| Q37511726 | The socioeconomic burden of SLE. |
| Q37421814 | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis |
| Q33621131 | Understanding the epidemiology and progression of systemic lupus erythematosus |
| Q38844782 | Update on cardiovascular disease in lupus |
| Q38591752 | Why are kids with lupus at an increased risk of cardiovascular disease? |
| Q38920435 | Why targeted therapies are necessary for systemic lupus erythematosus |
| Q82663605 | [Systemic lupus erythematosus--activity and outcome] |
| Q84566584 | [Systemic lupus erythematosus. A problem based approach] |
Search more.